Cytoreductive surgery
Splenectomy during cytoreductive surgery in epithelial ovarian cancer
... with cytoreductive surgery were collected from 2000 to 2015 at Peking Union Medical College ...cancer cytoreductive surgery at Peking Union Medical College Hospital between 2000 and 2015, of ...
10
Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
... undergoing cytoreductive surgery and intrathoracic hyperthermic perfusion with chemotherapy at our ...thoracoscopic surgery, the hyperthermic perfusion system was set up for hyperthermic intrapleural ...
5
Review Article Cytoreductive surgery combined with intraperitoneal chemotherapy in the treatment of colorectal peritoneal metastasis: a meta-analysis
... Received June 19, 2016; Accepted August 22, 2016; Epub November 15, 2016; Published November 30, 2016 Abstract: To use meta-analysis to investigate the effect and safety of cytoreductive surgery combined ...
9
Original Article The clinical study of secondary cytoreductive surgery in the treatment of low grade serous ovarian cancer
... secondary cytoreductive surgery mostly focused on the treatment for high-grade serous tumor [10, 11], while the therapeutic effect on low-grade serous tumors is still not ...secondary cytoreductive ...
8
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
... In a meta-analysis of the impact of intervals between sur- gery and initiation of adjuvant chemotherapy in the primary treatment of EOC, the intervals were not associated with survival [11]. However, the studies included ...
10
Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study
... In recent years, many institutions started treating pa- tients with cytoreductive surgery (CRS) and hyperthermia intraperitoneal chemotherapy (HIPEC). A 5-year survival between 33 and 58% has been described ...
7
Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
... Diagnostic laparoscopy prior to resection is widely used in hepatopancreaticobiliary and colorectal cancer and has been shown to be effective in excluding un- necessary laparotomy associated with higher morbidity ...
7
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
... Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has become the treatment of choice for resectable peritoneal carcinomatosis (PC) and improved the survival of ...
9
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver transplanted patient: a case report
... is termed CC0, and CC1 refers to residual disease less than 0.25 cm. CC2 and CC3 refers to residues between 0.25 – 2.5 cm and > 2.5 cm, respectively. Both CC0 and CC1 are considered as complete cytoreductive ...
5
Short Term And Follow Up Results Of Secondary Cytoreductive Surgery In Patients With Recurrent Ovarian Cancer
... secondary cytoreductive surgery (SCS) being considered as treatment : To assess short term and follow up outcomes of secondary cytoreductive surgery among recurrent ovarian cancer ...at ...
5
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
... Cytoreductive surgery was performed as described else- where [27], with the aim of complete cytoreduction (CC-0). When necessary, radical cytoreduction was asso- ciated with multivisceral resection, ...
9
Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
... Abstract: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a viable option for selected patients with peritoneal metastases (PM) from colorectal origin, resulting in ...
8
Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit
... each cytoreductive surgery; disease-free survival; number, maximum dimensions, type (peritoneal versus hematogenous), and intrahepatic distribution of the liver metastases; postoperative com- plications ...
6
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study
... called cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has been devel- oped over the past 3 decades, taking advantages of sur- gery to reduce visible tumor burden, and ...
9
Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: analysis from a single oncological center
... Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment analysis from a single oncological center RESEARCH Open Access Survival[.] ...
9
Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
... before surgery, usually scored by the peritoneal cancer index (PCI), and the quality of the surgical cytoreduction, measured by the completness of cytoreduction score (CCs) ...from cytoreductive ...
8
Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
... suboptimal cytoreductive surgery (SCS) (residual tumor of > 1 cm) using preoperative and intraoperative determination of the ...debulking surgery and thus included in the present ...
7
Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons
... cavity. Cytoreductive surgery (CRS) and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) have been used as the standard locoregional treat- ment for selected patients with PSM [3, ...
6
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
... introduced cytoreductive surgery (CRS) and hyperthermic intraperi- toneal chemotherapy (HIPEC) as a new innovative thera- peutic option for selected patients with peritoneal carcinomatosis ...
8
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Advanced Ovarian Carcinoma: Initial Experience in Mexico
... very high, and prognosis of recurrent disease is poor. Hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal metastases from epithelial ovarian cancer is a controversial treatment.The first report on EOC was in ...
5